Article, 2024

Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer - A phase II study

RADIOTHERAPY AND ONCOLOGY, ISSN 0167-8140, Volume 197, 10.1016/j.radonc.2024.110347

Contributors

Ejlsmark, M. (Corresponding author) [1] [2] Bahij, R. [1] [2] Schytte, Tine [1] [2] Hansen, Christian Ronn Bertelsen, Anders [1] [2] Mahmood, Faisal 0000-0001-6969-5574 [1] [2] Mortensen, M. B. 0000-0002-7270-5005 [1] [2] Detlefsen, S. [1] [2] Weber, Britta [3] Bernchou, Uffe [1] [2] Pfeiffer, Per [1] [2]

Affiliations

  1. [1] Odense Univ Hosp, Dept Oncol, Klovervaenget 8,Entrance 109, DK-5000 Odense, Denmark
  2. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Odense Univ Hosp, Dept Oncol, Klovervaenget 8,Entrance 109, DK-5000 Odense, Denmark
  4. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Aarhus Univ Hosp, Danish Ctr Particle Therapy, Aarhus, Denmark
  6. [NORA names: AU Aarhus University; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Ablative radiotherapy, Daily dose adaption, Locally advanced pancreatic cancer, MR-guided radiotherapy, MRI-Linac, Pancreatic cancer, SBRT, Stereotactic body radiation therapy

Data Provider: Clarivate